Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -59,995 | -75,595 | -113,575 | -291,955 | -276,011 |
| Depreciation Amortization | 10,033 | 8,077 | 7,384 | 2,811 | 1,149 |
| Accounts receivable | 2,353 | -8,123 | -11,103 | -9,670 | 0 |
| Accounts payable and accrued liabilities | -7,107 | -1,526 | -7,008 | 7,657 | 2,231 |
| Other Working Capital | 13,160 | 23,283 | -5,142 | 7,939 | 12,543 |
| Other Operating Activity | 42,329 | 76,260 | 105,339 | 110,748 | 118,398 |
| Operating Cash Flow | $773 | $22,376 | $-24,105 | $-172,470 | $-141,690 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -46 | -306 | -609 | -431 | -7,284 |
| Purchase Of Investment | -29,826 | -127,198 | -107,502 | -79,729 | -81,794 |
| Sale Of Investment | 73,275 | 132,667 | 50,488 | 114,724 | 231,267 |
| Purchase Sale Intangibles | -10,000 | N/A | N/A | -50,000 | 0 |
| Other Investing Activity | -10,000 | 0 | 0 | -50,000 | 0 |
| Investing Cash Flow | $33,403 | $5,163 | $-57,623 | $-15,436 | $142,189 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 8,444 | 25,000 | 105,000 | 50,000 | 0 |
| Debt Repayment | -8,444 | -80,000 | N/A | 0 | N/A |
| Common Stock Issued | 68 | 1,351 | 7,652 | 26,685 | 162,430 |
| Other Financing Activity | -10,000 | -13,418 | -4,201 | -1,575 | 0 |
| Financing Cash Flow | $-9,932 | $-67,067 | $108,451 | $75,110 | $162,430 |
| Beginning Cash Position | 73,210 | 112,738 | 86,015 | 198,811 | 35,882 |
| End Cash Position | 97,454 | 73,210 | 112,738 | 86,015 | 198,811 |
| Net Cash Flow | $24,244 | $-39,528 | $26,723 | $-112,796 | $162,929 |
| Free Cash Flow | |||||
| Operating Cash Flow | 773 | 22,376 | -24,105 | -172,470 | -141,690 |
| Capital Expenditure | -46 | -306 | -609 | -431 | -7,284 |
| Free Cash Flow | 727 | 22,070 | -24,714 | -172,901 | -148,974 |